IPATASERTIB for Hormone-refractory prostate cancer: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 14 adverse event reports in the FDA FAERS database where IPATASERTIB was used for Hormone-refractory prostate cancer.
Most Reported Side Effects for IPATASERTIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Diarrhoea | 17 | 13.6% | 4 | 11 |
| Pyrexia | 11 | 8.8% | 0 | 10 |
| Fatigue | 10 | 8.0% | 1 | 5 |
| Hyperglycaemia | 9 | 7.2% | 3 | 5 |
| Rash | 8 | 6.4% | 2 | 4 |
| Nausea | 7 | 5.6% | 2 | 2 |
| Vomiting | 7 | 5.6% | 2 | 3 |
| Acute kidney injury | 6 | 4.8% | 0 | 6 |
| Pneumonitis | 6 | 4.8% | 1 | 2 |
| Rash maculo-papular | 6 | 4.8% | 0 | 4 |
| Anaemia | 5 | 4.0% | 2 | 2 |
| Dehydration | 5 | 4.0% | 0 | 5 |
| Drug ineffective | 5 | 4.0% | 0 | 1 |
Other Indications for IPATASERTIB
Triple negative breast cancer (26)
Breast cancer (17)
Prostate cancer (11)
Breast cancer metastatic (9)
Prostate cancer metastatic (8)
Her2 negative breast cancer (7)
Neoplasm (7)
Other Drugs Used for Hormone-refractory prostate cancer
ENZALUTAMIDE (8,881)
RADIUM RA-223 DICHLORIDE (1,615)
ABIRATERONE (1,378)
DOCETAXEL (674)
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN (579)
DAROLUTAMIDE (553)
CABAZITAXEL (524)
PREDNISONE (474)
APALUTAMIDE (365)
OLAPARIB (313)